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schemic Versus Nonischemic
hest Pain in the Emergency Room
choes of Contrast*
ani A. Vannan, MBBS, FACC,
agat Narula, MD, PHD, FACC
rvine, California
ore than six million patients present with chest pain and
uspected acute coronary syndrome (ACS) to emergency
epartments (EDs) across the U.S. annually (1,2). These
atients require rapid and efficient triage to hospitalization
ersus discharge to maximize appropriate allocation of
esources to the highest-risk patients who require timely
ife-saving therapy. The 12-lead electrocardiogram (ECG)
nd serial cardiac enzymes, which are the cornerstone of
ecision-making in the ED, have significant shortcomings.
s many as 50% of patients have a nondiagnostic ECG, and
ardiac injury markers frequently are normal in the early
ours of ACS (3). These findings, when combined with
nadvertent discharge of 2% to 4% of patients with ACS and
he fact that missed ACS is one of the leading causes of
itigation against EDs, has meant that the threshold of hospi-
alization has remained suboptimal (4).
See page 920
Therefore, it is imperative that we continue to find
lgorithms that may help to reliably identify the lowest-risk
atients who may not even have coronary artery disease
CAD) because the economic burden of hospitalization of
hese patients is enormous. During the last decade, chest
ain units (CPUs) in the ED were born out of such an effort
o triage patients with intermediate- and low-risk for ACS
5). Typically, these units hold patients for as long as 12 h
or clinical observation, during which time serial ECGs and
ardiac enzymes are performed. A positive evaluation leads
o hospitalization, whereas a negative evaluation leads to
tress testing or discharge without stress testing.
The role of exercise electrocardiography (ExECG) in the
D among patients with intermediate or low risk for ACS
as been tested in a number of studies (6,7). On the basis of
he collective data, it can be surmised that ExECG is a good
nd cost-effective test to triage patients with intermediate
isk. There are, however, several limitations to ExECG: the
ercentage of patients who present to the ED and are
nable to exercise has been reported to be as high as 35%,
*Editorials published in the Journal of the American College of Cardiology reflect the
iews of the authors and do not necessarily represent the views of JACC or the
merican College of Cardiology.p
From the Division of Cardiology, Department of Medicine, University of Califor-
ia at Irvine, Irvine, California.he rate of suboptimal exercise is largely unaccounted for in
he published studies, the rate of false-positive tests is
nacceptably high especially among women. Furthermore,
tress imaging testing has been shown to have excellent
ccuracy and cost-benefit in stratifying patients in the
D (8).
Multiple imaging studies have been performed in the ED
nd CPU settings in patients with suspected ACS or those
ho were admitted with the diagnosis of acute myocardial
nfarction. Resting echocardiograms have been reported to
e 90% sensitive and 65% specific for the diagnosis of
CS or acute myocardial infarction (9). A large randomized
tudy of rest nuclear imaging in the ED showed that there
as a 10% absolute reduction in hospitalization in patients
ith chest pain and nondiagnostic ECG when perfusion
ata was included in the decision-making (8). The study by
ong et al. (10) in this issue of the Journal is an important
ddition to the accumulating evidence for using imaging in
PUs for efficient assignment of patients to admission
ersus discharge. They studied contrast echocardiography
CE) compared with a modified Thrombolysis In Myocar-
ial Infarction (TIMI) score for triage of nearly 1,000
atients presenting with chest pain and nondiagnostic
CG. Both regional myocardial function and perfusion
ere analyzed by rest CE and related to early (in the first
4 h), intermediate (at 30 days), and late (1 year) events.
he comparison of CE was performed with the modified
IMI (mTIMI) score, which initially did not include serum
roponin levels. Troponin levels became available during the
PU stay after CE was performed. The presence of normal
egional function (RF) was most efficient in predicting
owest risk in the first 24 h.
The lowest mTIMI score failed to identify approximately
% of ACS (myocardial infarction), which is consistent with
revious data. Further, CE also was able to classify patients
ith an intermediate mTIMI score into low risk (normal
F) and high risk (abnormal RF) for ACS. For a given RF
nding, the presence of perfusion abnormality by CE was
ndicative of the highest risk whereas normal perfusion
dentified a very low risk (0.4%) for ACS. Even the
ubsequent complete TIMI score (which included the tro-
onin level) failed to predict up to 5% of early events. These
ndings are a confirmation that clinical variable plus cardiac
nzymes alone are insufficient to adequately triage low- and
ntermediate-risk patients in the CPU, and the reliable
iscrimination would need the aid of an imaging test.
Which imaging test does one choose? In the case of
uclear imaging, the wealth of experience with myocardial
erfusion imaging, the safety of adenosine or stress imaging,
nd the recent approach of using fatty acid imaging to
dentify ischemic memory offer tremendous advantages in
he ED (11). However, the ability to readily obtain infor-
ation on left ventricular regional function and perfusion by
est CE at the bedside is a significant advantage from a
ractical standpoint and universal applicability. Previous
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September 6, 2005:928–9 Editorial Commentchocardiographic studies in the ED were performed at a
ime when a significant proportion of transthoracic echo-
ardiograms were suboptimal, thus limiting the clinical
pplicability of the approach. The advent of CE and new
ransducer technology has had a tremendous positive impact
n image quality, making transthoracic echocardiography
nterpretable in 90% of studies. Current transducer and
quipment technology also allow myocardial perfusion im-
ging with little additional operator interaction.
The limitations of CE have to do with the traditional
rguments of image quality and operator dependency of
chocardiography. Contrast echocardiography has made the
ormer problem a rarity and, with CE wall motion and
hickening, can be appreciated even by a modestly trained
ye. Interpretation of perfusion may be more challenging for
he untrained eye. However, the growth of telemedicine
eans that the expert can both guide the acquisition and
ead the information in real time. These issues are not
rohibitory to the application of CE or, for that matter, any
maging modality in the ED. Recent experimental data
rom work on targeted imaging using either radioisotopes or
icrobubbles add another exciting dimension to imaging in
he ED. For example, annexin-A5 can be bound to polymer
icrobubbles, which can then be insonated with ultrasound
o image myocyte apoptosis in the infarcted myocardium
12). It is also possible that the endothelial alterations
uring ischemic injury will also offer a convenient target for
E in the ED in the future (13).
There are challenges to contend with implementation of
maging in the CPU protocol for triage. Patients with chest
ain who present after-hours to the ED require additional
esources that have to be specifically allocated, readily
vailable, and carefully monitored (e.g., the quality of the
ata obtained during “after hours”). The economics of
maging, whether it be rest or stress imaging in the CPU, is
ncertain. Contrast echocardiography will certainly have
ore resource-based relative value units than standard
oncontrast two-dimensional echocardiography but this
ould still favorably compare with resting or stress nuclear
esting. There is a burgeoning interest in studying the role
f multislice computed tomography imaging of coronary
natomy in patients presenting to the CPU in the ED.
hether multislice computed tomography will cut into or
omplement CE or nuclear imaging remains to be seen.
ardiac magnetic resonance seems to be least practical
ecause of the time it takes to obtain an image. Finally, the
dverse clinical outcome and the fear of litigation of missed
CS in 1% of patients have been strong deterrents to the
mplementation of any of the early diagnostic protocols in
he ED. This issue has been amplified by the uncertainty of
arginal elevations of troponin in the setting of atypical
ymptoms and suspected ACS. All of this has further fueled
he practice of watchful waiting in the CPU, with itsttendant enormous cost burden. Imaging stress testing may
lleviate some of this burden and arguably improve the
fficiency and effectiveness of triage of patients in the CPU
y bringing the cardiologist into play early in the process of
linical decision-making.
Echocardiography may be uniquely placed in the CPU as
practical and efficient imaging modality for rest or stress
maging. However, CE will have to be tested widely for
ifferentiating ischemic from nonischemic origin of chest
ain in the ED.
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